-
Something wrong with this record ?
Enhanced antitumor activity of surface-modified iron oxide nanoparticles and an α-tocopherol derivative in a rat model of mammary gland carcinosarcoma
D. Horák, VI. Pustovyy, AV. Babinskyi, OM. Palyvoda, VF. Chekhun, IN. Todor, OI. Kuzmenko,
Language English Country New Zealand
Document type Journal Article
NLK
Directory of Open Access Journals
from 2006
Free Medical Journals
from 2006
PubMed Central
from 2006
Europe PubMed Central
from 2006
ProQuest Central
from 2012-01-01
Open Access Digital Library
from 2006-01-01
Open Access Digital Library
from 2009-01-01
Taylor & Francis Open Access
from 2006-09-01
Medline Complete (EBSCOhost)
from 2012-01-01
Health & Medicine (ProQuest)
from 2012-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2006
PubMed
28652731
DOI
10.2147/ijn.s137574
Knihovny.cz E-resources
- MeSH
- Acrylamides chemistry MeSH
- alpha-Tocopherol administration & dosage chemistry MeSH
- Mammary Neoplasms, Experimental drug therapy MeSH
- Carcinosarcoma drug therapy MeSH
- Drug Delivery Systems methods MeSH
- Magnetite Nanoparticles administration & dosage chemistry MeSH
- Rats, Wistar MeSH
- Spectroscopy, Fourier Transform Infrared MeSH
- Microscopy, Electron, Transmission MeSH
- Dose-Response Relationship, Drug MeSH
- Ferric Compounds chemistry MeSH
- Animals MeSH
- Check Tag
- Female MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
Maghemite (γ-Fe2O3) nanoparticles were obtained by coprecipitation of ferrous and ferric salts in an alkaline medium followed by oxidation; the nanoparticles were coated with poly(N,N-dimethylacrylamide) (PDMA) and characterized by transmission electron microscopy, attenuated total reflection (ATR) Fourier transform infrared (FTIR) spectroscopy, dynamic light scattering, thermogravimetric and elemental analyses, and magnetic measurements in terms of particle morphology, size, polydispersity, amount of coating, and magnetization, respectively. The effects of α-tocopherol (Toc) and its phenolic (Toc-6-OH) and acetate (Toc-6-Ac) derivatives on Fe2+ release from γ-Fe2O3@PDMA, as well as from γ-Fe2O3 and CuFe2O4 nanoparticles (controls), were examined in vitro using 1,10-phenanthroline. The presence of tocopherols enhanced spontaneous Fe2+ release from nanoparticles, with Toc-6-OH exhibiting more activity than neat Toc. All of the nanoparticles tested were found to initiate blood lipid oxidation in a concentration-dependent manner, as determined by analysis of 2-thiobarbituric acid reactive species. Wistar rats with Walker-256 carcinosarcoma (a model of mammary gland carcinosarcoma) received Toc-6-Ac, magnetic nanoparticles, or their combination per os, and the antitumor activity of each treatment was determined in vivo. γ-Fe2O3@PDMA nanoparticles exhibited increased antitumor activity compared to both commercial CuFe2O4 particles and the antitumor drug doxorubicin. Moreover, increased antitumor activity was observed after combined administration of γ-Fe2O3@PDMA nanoparticles and Toc-6-Ac; however, levels of bilirubin, aspartate aminotransferase, and white bloods normalized and did not differ from those of the intact controls. The antitumor activity of the γ-Fe2O3 nanoparticles strongly correlated with Fe2+ release from the nanoparticles but not with nanoparticle-initiated lipid peroxidation in vitro.
Department of Polymer Particles Institute of Macromolecular Chemistry AS CR Prague Czech Republic
Department of Vitamins and Coenzyme Biochemistry Palladin Institute of Biochemistry NASU Ukraine
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18016515
- 003
- CZ-PrNML
- 005
- 20180516135816.0
- 007
- ta
- 008
- 180515s2017 nz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.2147/IJN.S137574 $2 doi
- 035 __
- $a (PubMed)28652731
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a nz
- 100 1_
- $a Horák, Daniel $u Department of Polymer Particles, Institute of Macromolecular Chemistry AS CR, Prague, Czech Republic.
- 245 10
- $a Enhanced antitumor activity of surface-modified iron oxide nanoparticles and an α-tocopherol derivative in a rat model of mammary gland carcinosarcoma / $c D. Horák, VI. Pustovyy, AV. Babinskyi, OM. Palyvoda, VF. Chekhun, IN. Todor, OI. Kuzmenko,
- 520 9_
- $a Maghemite (γ-Fe2O3) nanoparticles were obtained by coprecipitation of ferrous and ferric salts in an alkaline medium followed by oxidation; the nanoparticles were coated with poly(N,N-dimethylacrylamide) (PDMA) and characterized by transmission electron microscopy, attenuated total reflection (ATR) Fourier transform infrared (FTIR) spectroscopy, dynamic light scattering, thermogravimetric and elemental analyses, and magnetic measurements in terms of particle morphology, size, polydispersity, amount of coating, and magnetization, respectively. The effects of α-tocopherol (Toc) and its phenolic (Toc-6-OH) and acetate (Toc-6-Ac) derivatives on Fe2+ release from γ-Fe2O3@PDMA, as well as from γ-Fe2O3 and CuFe2O4 nanoparticles (controls), were examined in vitro using 1,10-phenanthroline. The presence of tocopherols enhanced spontaneous Fe2+ release from nanoparticles, with Toc-6-OH exhibiting more activity than neat Toc. All of the nanoparticles tested were found to initiate blood lipid oxidation in a concentration-dependent manner, as determined by analysis of 2-thiobarbituric acid reactive species. Wistar rats with Walker-256 carcinosarcoma (a model of mammary gland carcinosarcoma) received Toc-6-Ac, magnetic nanoparticles, or their combination per os, and the antitumor activity of each treatment was determined in vivo. γ-Fe2O3@PDMA nanoparticles exhibited increased antitumor activity compared to both commercial CuFe2O4 particles and the antitumor drug doxorubicin. Moreover, increased antitumor activity was observed after combined administration of γ-Fe2O3@PDMA nanoparticles and Toc-6-Ac; however, levels of bilirubin, aspartate aminotransferase, and white bloods normalized and did not differ from those of the intact controls. The antitumor activity of the γ-Fe2O3 nanoparticles strongly correlated with Fe2+ release from the nanoparticles but not with nanoparticle-initiated lipid peroxidation in vitro.
- 650 _2
- $a akrylamidy $x chemie $7 D000178
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a karcinosarkom $x farmakoterapie $7 D002296
- 650 _2
- $a vztah mezi dávkou a účinkem léčiva $7 D004305
- 650 _2
- $a lékové transportní systémy $x metody $7 D016503
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a železité sloučeniny $x chemie $7 D005290
- 650 _2
- $a magnetické nanočástice $x aplikace a dávkování $x chemie $7 D058185
- 650 _2
- $a experimentální nádory mléčných žláz $x farmakoterapie $7 D008325
- 650 _2
- $a transmisní elektronová mikroskopie $7 D046529
- 650 _2
- $a potkani Wistar $7 D017208
- 650 _2
- $a spektroskopie infračervená s Fourierovou transformací $7 D017550
- 650 _2
- $a alfa-tokoferol $x aplikace a dávkování $x chemie $7 D024502
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Pustovyy, Vitaliy Igorovych $u Department of Vitamins and Coenzyme Biochemistry, Palladin Institute of Biochemistry, NASU, Ukraine.
- 700 1_
- $a Babinskyi, Andrii Valeriyovich $u Department of Vitamins and Coenzyme Biochemistry, Palladin Institute of Biochemistry, NASU, Ukraine.
- 700 1_
- $a Palyvoda, Olga Mikhailovna $u Department of Vitamins and Coenzyme Biochemistry, Palladin Institute of Biochemistry, NASU, Ukraine.
- 700 1_
- $a Chekhun, Vasyl Fedorovich $u Department of Mechanisms of Antitumor Therapy, R. E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, NASU, Ukraine.
- 700 1_
- $a Todor, Igor Nikolaevich $u Department of Mechanisms of Antitumor Therapy, R. E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, NASU, Ukraine.
- 700 1_
- $a Kuzmenko, Oleksandr Ivanovich $u Department of Vitamins and Coenzyme Biochemistry, Palladin Institute of Biochemistry, NASU, Ukraine.
- 773 0_
- $w MED00176143 $t International journal of nanomedicine $x 1178-2013 $g Roč. 12, č. - (2017), s. 4257-4268
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/28652731 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20180515 $b ABA008
- 991 __
- $a 20180516135951 $b ABA008
- 999 __
- $a ok $b bmc $g 1300139 $s 1013355
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 12 $c - $d 4257-4268 $e 20170606 $i 1178-2013 $m International journal of nanomedicine $n Int J Nanomedicine $x MED00176143
- LZP __
- $a Pubmed-20180515